· Led by Voima Ventures and co-led by existing investor Eir Ventures · Funding will support continued development of Auga sensor system platform to accelerate the bioprocessing workflow from early upstream to late formulation Stockholm, Sweden: ArgusEye, a provider of innovative sensor solutions for real-time monitoring of biological systems, today announced the close of its funding, raising […]
SAN CARLOS, Calif. — Cache DNA, Inc., a life sciences company revolutionizing biological sample and data storage infrastructure, today announced the closing of its seed round. The team raised an undisclosed amount from notable investors, including Climate Capital Bio, Exor Ventures, Hawktail, LifeX Ventures, Pillar VC, and Trousdale Ventures, including support from Illumina and founders […]
SAN DIEGO — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its groundbreaking Gibson SOLA platform. Going forward, the company will increasingly concentrate its efforts on expanding the adoption of Gibson SOLA for both DNA and […]
Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 – $75 Million Q1 2024 Earnings Conference Call Scheduled for May 9, 2024 MENLO PARK, Calif. – PacBio (NASDAQ: PACB) today announced preliminary, unaudited revenue for the quarter ended March 31, 2024. Preliminary First Quarter Results Preliminary revenue of $38.8 million, roughly flat compared with $38.9 million in the prior-year period. Instrument revenue of $19.0 million compared with $20.7 million in the prior-year […]
Isospec Analytics launches its breakthrough biomolecular analysis technology that identifies unknown molecules at scale for pharmaceutical, agritech and nutrition companies. Lausanne, Switzerland When developing new drugs, nutitional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too often unsuccessful, leading to failed regulatory processes, […]
WATERTOWN, Mass. — Spectaire Holdings Inc. (NASDAQ: SPEC) (“Spectaire”) has announced that it has closed a $2.0 million private placement with True Remainders Ltd. for the sale and issuance of (i) an aggregate of 1,538,461 shares of Spectaire common stock, and (ii) an accompanying warrant to purchase up to 1,538,461 shares of Spectaire common stock […]
Proceeds support continued development and commercialization of cell engineering platform technology across research and clinical applications. Over 20 active partners to date, ranging from large pharmaceutical and biotechnology companies to leading academic institutions. CAMBRIDGE, Mass. — Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, […]
Proceeds to launch new RNA sequencing products, expand production capacity, develop new technologies and open US subsidiary. LAUSANNE, Switzerland — Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of a CHF 2.8 million ($3.2 million) extension to its seed financing. The round was led by the Novalis […]
Company to Provide Broader Access to its AI-Driven Cell-Free Protein Production Platform SAN LEANDRO, Calif. — Tierra Biosciences, the company behind the world’s first platform for predictive AI-guided cell-free technology enabling high-throughput on-demand custom protein synthesis, announced today that it closed an $11.4M Series A round. The investment was led by Material Impact with participation from new […]
Cambridge, Mass. – Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has announced a significant capital raise to fuel its continued growth and execution of long-term vision. At the same time, the company has also taken steps to streamline its operations and reduce headcount. These measures […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
